drugset / Trial / NCT02182375
Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
Study to investigate the effect of UGT1A1 inhibition by single and multiple oral doses of BI 201335 on the single and multiple oral dose pharmacokinetics of raltegravir and to investigate safety and tolerability.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Faldaprevir | Small molecule | 240 mg | Oral |
| Subject | Raltegravir | Other / unclassified | 400 mg | Oral |
Indications
No indication recorded.